Immediate Start!!
About Us
PentaBind is the first aptamer discovery company using AI and a fully-integrated wet laboratory to design a new generation of alternative oligo therapeutics. Our pioneering platform already improves the experimental search space by 300x, generating therapeutic aptamers for urgent clinical needs within oncology, rare and neurodegenerative diseases.
We are a VC-backed pre-seed startup with a lab in White City, supported by Twin Path, Entrepreneur First, KQ labs among others. Currently a team of 8, and growing to 14 people in the next 12 months. See our video pitch here (https://docsend.com/view/c47hx5re555ibnij), and our founder video story here (https://docsend.com/view/a7gzjub2ppnnzawr). PentaBind has been shortlisted as New Startup of the Year by Cancer Research Horizons, and also as Deep Tech Investment of the Year by the UK Business Angels Association, a prestigious award sponsored by the Royal Academy of Engineering.
Our Vision
Learn about our vision, our culture and what to expect here (https://www.pentabind.com/about).
About this Role:
This position will focus on the design and development of both a small-molecule SELEX and a proprietary aptamer selection pipeline, in the context of an early-stage AI drug discovery company. The SELEX pipeline will be an integral part of our AI-wet-lab feedback loop. The position may also offer outstanding opportunities to work on state-of-the-art high-throughput platforms, automation and other biophysical studies. This role is ideally suited for a motivated experimental scientist who is passionate about pharmaceuticals and technology.
Key Responsibilities:
Ideal Candidate:
Desired Candidate:
Lifelancer ( https://lifelancer.com ) is a talent-hiring platform in Life Sciences, Pharma and IT. The platform connects talent with opportunities in pharma, biotech, health sciences, healthtech and IT domains.
Please use the below Lifelancer link to Apply and view similar roles.
https://lifelancer.com/jobs/view/67969d7dac947a56aca1452ab466a98e